Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 713,000 | N/A | N/A | N/A |
| Depreciation Amortization | 172,000 | N/A | N/A | N/A |
| Other Working Capital | 69,000 | N/A | N/A | N/A |
| Other Operating Activity | -374,000 | 0 | 0 | 0 |
| Operating Cash Flow | $580,000 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -313,000 | N/A | N/A | N/A |
| Other Investing Activity | 133,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-180,000 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | -186,000 | N/A | N/A | N/A |
| Other Financing Activity | 454,000 | 0 | 0 | 0 |
| Financing Cash Flow | $268,000 | $N/A | $N/A | $N/A |
| End Cash Position | 668,000 | N/A | N/A | N/A |
| Net Cash Flow | $668,000 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 580,000 | N/A | N/A | N/A |
| Free Cash Flow | 580,000 | 0 | 0 | 0 |